IRIS
BIZZARRO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.143
NA - Nord America 4.976
AS - Asia 2.525
SA - Sud America 328
Continente sconosciuto - Info sul continente non disponibili 49
AF - Africa 23
OC - Oceania 8
Totale 15.052
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.888
RU - Federazione Russa 4.425
SG - Singapore 963
IE - Irlanda 778
CN - Cina 609
UA - Ucraina 445
GB - Regno Unito 371
HK - Hong Kong 355
DE - Germania 313
IT - Italia 298
BR - Brasile 276
VN - Vietnam 199
FI - Finlandia 157
SE - Svezia 151
TR - Turchia 113
IN - India 98
FR - Francia 62
GR - Grecia 59
BD - Bangladesh 47
CA - Canada 45
KR - Corea 42
JP - Giappone 38
BE - Belgio 21
AR - Argentina 15
MX - Messico 13
ID - Indonesia 11
IQ - Iraq 11
CO - Colombia 10
ZA - Sudafrica 10
CZ - Repubblica Ceca 9
PL - Polonia 9
EC - Ecuador 8
ES - Italia 8
AU - Australia 7
TT - Trinidad e Tobago 7
NL - Olanda 6
UZ - Uzbekistan 6
CL - Cile 5
MY - Malesia 5
PY - Paraguay 5
RO - Romania 5
VE - Venezuela 5
AT - Austria 4
GT - Guatemala 4
JM - Giamaica 4
MA - Marocco 4
SV - El Salvador 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CH - Svizzera 3
CR - Costa Rica 3
EE - Estonia 3
LT - Lituania 3
PK - Pakistan 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
BG - Bulgaria 2
EG - Egitto 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
LU - Lussemburgo 2
NI - Nicaragua 2
PE - Perù 2
PH - Filippine 2
TW - Taiwan 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
DM - Dominica 1
EU - Europa 1
GA - Gabon 1
GP - Guadalupe 1
IR - Iran 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MN - Mongolia 1
MT - Malta 1
MW - Malawi 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
TN - Tunisia 1
VC - Saint Vincent e Grenadine 1
Totale 15.006
Salva come PNG Salva come JPEG
Città #
Moscow 1.552
Dublin 777
Jacksonville 656
Chandler 530
San Jose 519
Santa Clara 457
Singapore 392
Hong Kong 348
Ashburn 331
Council Bluffs 224
Dallas 175
Princeton 115
New York 114
Boardman 100
Medford 100
Ann Arbor 96
Beijing 90
San Mateo 82
Bengaluru 78
Hefei 75
Munich 65
Wilmington 64
Ho Chi Minh City 62
Milan 58
Woodbridge 57
Hanoi 56
Helsinki 44
The Dalles 43
Düsseldorf 39
Seoul 36
Los Angeles 31
Miano 27
Cambridge 26
Roxbury 26
São Paulo 22
Brussels 21
Bremen 20
Nanjing 17
Orem 17
Venice 17
Auburn Hills 16
Shenyang 16
Caserta 15
Des Moines 14
Jinan 14
Naples 13
Norwalk 13
Rome 13
Frankfurt am Main 12
Guangzhou 12
Mountain View 12
Tianjin 11
Brooklyn 10
Da Nang 10
Houston 10
Tokyo 10
Atlanta 9
Nanchang 9
San Francisco 9
Warsaw 9
Brno 8
Rio de Janeiro 8
Salerno 8
Brasília 7
Dearborn 7
Hanover 7
Lanzhou 7
Memphis 7
Montreal 7
Ottawa 7
Seattle 7
Zhengzhou 7
Chennai 6
Chicago 6
Curitiba 6
Florence 6
Hải Dương 6
Istanbul 6
Kunming 6
Minneapolis 6
Porto Alegre 6
Tashkent 6
West Jordan 6
Cimitile 5
Dhaka 5
Elora 5
Haiphong 5
Hangzhou 5
Hillsboro 5
Johannesburg 5
Kocaeli 5
London 5
North Bergen 5
Quảng Ngãi 5
Redwood City 5
Shanghai 5
Tampa 5
Toronto 5
Amsterdam 4
Ankara 4
Totale 8.032
Salva come PNG Salva come JPEG
Nome #
1) A new approach to the study of Graves Ophthalmopathy: Standardized A-Scan Echography and Octreotide scintigraphy as possible parameters for disease activity 451
Detection of antipituitary and antihypothalamus antibodies to investigate the role of pituitary or hypothalamic autoimmunity in patients with selective idiopathic hypopituitarism 214
A five year prospective investigation of anterior pituitary function after traumatic brain injury: is hypopituitarism long-term after head trauma associated with autoimmunity? 205
ective investigation of pituitary functions in patients with acute infectious meningitis: is acute meningitis induced pituitary dysfunction associated with autoimmunity? 197
Diagnostic evaluation of a patient with suspected Cushing’s Syndrome and hyperandrogenism: metabolic and clinical aspects for a correct differential diagnosis 194
Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma 191
Autoimmune thyroid disease and neuroendocrine gastric tumors: early detection and efficacy of somatostatin analogue treatment. 190
(2008). Effect of long-term cabergoline therapy on the immunological pattern and pituitary function of patients with idiopathic hyperprolactinaemia positive for antipituitary antibodies. 2008 187
ANTIBODIES AGAINST GONADOTROPIN-SECRETING CELLS IN PATIENTS WITH APPARENTLY IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM 186
ANTIBODIES AGAINST GONADOTROPIN-SECRETING CELLS IN PATIENTS WITH KALLMANN’S SYNDROME AND IN PATIENTS WITH APPARENTLY IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM 186
Predictive role of the immunostaining pattern of immunofluorescence and the titers of antipituitary antibodies at presentation for the occurrence of autoimmune hypopituitarism in patients with autoimmune polyendocrine syndromes over a five-year follow-up 185
Antipituitary antibodies against gonadotropin-secreting cells in adult male patients with apparently idiopathic hypogonadotropic hypogonadism. 185
Anti-hypothalamus and anti-pituitary antibodies may contribute to perpetuate the hypopituitarism in patients with Sheehan's syndrome. 182
Anticorpi antimuscolo oculare e molecole di adesione come markers immunologici nell' oftalmopatia basedowiana 179
Prospective investigation of pituitary functions in patients with acute infectious meningitis: is acute meningitis induced pituitary dysfunction associated with autoimmunity? 175
Characterization of pituitary cells targeted by antipituitary antibodies in patients with isolated autoimmune diseases without pituitary insufficiency may help to foresee the kind of future hypopituitarism. 174
[T-lymphocyte subpopulations in the conjunctiva of subjects with secondary Sjogren's syndrome] 172
Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects 171
111In-octreotide in autoimmune thyroid disease and in the evaluation of active exophthalmos 168
Antipituitary antibodies after traumatic brain injury: is head trauma-induced pituitary dysfunction associated with autoimmunity? 165
Behavior of sICAM-1 and sELAM-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma 165
PREGNANCY MAY FAVOUR THE DEVELOPMENT OF SEVERE AUTOIMMUNE CENTRAL DIABETES INSIPIDUS IN WOMEN WITH VASOPRESSIN-CELL ANTIBODIES: DESCRIPTION OF TWO CASES 164
111In-octreotide in the evaluation of autoimmune thyroid diseases 163
A new approach to the study of Graves Ophthalmopathy: Standardized A-Scan Echography and Octreotide scintigraphy as possible parameters for disease activity 161
Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies 160
Anti-Pituitary Antibodies in Children With Newly Diagnosed Celiac Disease: A Novel Finding Contributing to Linear-Growth Impairment 156
A new ELISA assay for islet cell surface antibodies determination in type 1 diabetes mellitus of recent onset 156
Detection of vasopressin cell antibodies in some patients with autoimmune endocrine diseases without overt diabetes insipidus 154
Peripheral blood mononuclear cell populations in men with "idiopathic" infertility with antisperm autoantibodies 154
Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study 153
[TAC-positive lymphocytes in Basedow's disease] 153
[Serum tumor markers in lung neoplasms (correlation with histological types)] 147
Relationship between Graves' ophthalmopathy activity and serum immunological markers (anti-ocular muscle antibody, soluble adhesion molecules) 146
A longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidus 145
[Effect of pretreatment with metoclopramide on plasma prolactin response to methergoline] 143
Sindromi poliendocrine autoimmuni 142
PITUITARY ANTIBODIES AND LYMPHOCYTIC HYPOPHYSITIS 140
Hashimoto’s thyroiditis and entero-chromaffin-like cell hyperplasia: early detection and somatostatin analogue treatment. 139
[Effect of cyproheptadine on plasma ACTH and cortisol secretion in a patient with Cushing's disease] 138
[Autoimmune Addison's disease. Current knowledge and prospects] 137
T-lymphocyte subsets in pregnant women with Graves' disease 137
Cytomegalovirus and male infertility 137
Longitudinal behavior of autoimmune GH deficiency: from childhood to transition age. 136
Late primary autoimmune hypothyroidism in a patient with postdelivery autoimmune hypopituitarism associated with antibodies to growth hormone and prolactin-secreting cells. 135
Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease 135
Subclinical diabetes insipidus 134
Italian Addison network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency 133
Immunological and clinical aspects of lymphocytic hypophysitis 132
Antipituitary antibodies recognizing growth hormone (GH)-producing cells in children with idiopathic GH deficiency and in children with idiopathic short stature 132
CD11B lymphocytes in type 1 diabetes mellitus of recent onset 132
[Anti-rubella antibodies in neapolitan females. Correlation with age and work (author's transl)] 131
[Effects of pentobarbital on serum levels of LH and FSH, in normal conditions and after GnRH stimulation: preliminary report] 130
Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity 130
[Role of flowmetric analysis and of color-Doppler ultrasonography with contrast media in the different phases and follow-up of Graves' disease] 130
SIMULTANEOUS EVALUATION OF THE CIRCULATING LEVELS OF BOTH Th1 AND Th2 CHEMOKINES IN PATIENTS WITH AUTOIMMUNE ADDISON'S DISEASE 129
Indio-111 Octreotide nelle malattie tiroidee autoimmuni e nella oftalmopatia attiva 129
Autoimmunity as a possible cause of growth hormone deficiency 128
T-lymphocyte-subsets in endocrine exophthalmos 126
neoplasie endocrine multiple 126
Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism 125
Antipituitary antibodies in adults with apparently idiopathic growth hormone deficiency and in adults with autoimmune endocrine diseases 125
Characterization of antipituitary antibodies targeting pituitary hormone-secreting cells in idiopathic growth hormone deficiency and autoimmune endocrine diseases 124
[Blood levels of neopterin in patients with liver cirrhosis] 124
[Effect of TRH on growth hormone (GH) release induced with ACTH] 124
Soluble intercellular adhesion molecule-1 (sICAM-1) concentrations in Graves' disease patients followed up for development of ophthalmopathy 123
Medial arterial calcification and diabetic neuropathy 122
[Effect of metoclopramide on growth hormone (GH) release induced with ACTH] 122
Vasopressin cell antibodies and central diabetes insipidus in a patient with systemic lupus erythematosus and dermatomyositis 121
Soluble CD8 antigen, stimulated C-peptide and islet cell antibodies are predictors of insulin requirement in newly diagnosed patients with unclassifiable diabetes 121
[Effect of atropine on hypophyseal gonadotropins in the basal condition and under GnRH stimulation] 121
Time course of 21-hydroxylase antibodies and long-term remission of subclinical autoimmune adrenalitis after corticosteroid therapy: case report 120
Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease 120
Influence of testosterone therapy on clinical and immunological features of autoimmune diseases associated with Klinefelter's syndrome 120
COMPORTAMENTO DEL PEPTIDE PROCOLLAGENO III N TERMINALE NEL SIERO DI PAZIENTI CON OFTALMOPATIA BASEDOWIANA CON O SENZA IPERTIROIDISMO 117
INVOLVEMENT OF HYPOTHALAMUS AUTOIMMUNITY IN PATIENTS WITH AUTOIMMUNE HYPOPITUITARISM: ROLE OF ANTIBODIES TO HYPOTHALAMIC CELLS 116
Inhibiting effect of atropine on prolactin blood levels after stimulation with TRH 116
Central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical, immunological, and radiological features in a large cohort of patients with central diabetes insipidus of known and unknown etiology 115
Role of flowmetric analysis and of color-Doppler ultrasonography with contrast media in the different phases and follow-up of Graves' diseas 115
Rituximab-induced remission of autoimmune hypophysitis and primary immune thrombocytopenia in a patient with autoimmune polyendocrine syndrome type 4 115
[Effect of surgical stress on TSH and on the extra-thyroid metabolism of T4 (preliminary experiment)] 115
Investigation of antihypothalamus and antipituitary antibodies in amateur boxers: is chronic repetitive head trauma-induced pituitary dysfunction associated with autoimmunity? 114
Lymphocytic hypophysitis: a rare or underestimated disease? 113
Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves' ophthalmopathy receiving corticosteroid therapy 113
Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy 112
Antipituitary antibodies in idiopathic hyperprolactinemic patients 112
Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism 111
Serum levels of soluble intercellular adhesion molecule 1 (sICAM-1) as a potential marker of disease activity and remission in patients with chronic hepatitis C 111
Prolactin and autoimmunity 111
Light, blindness and endocrine secretions 111
INCREASED SERUM LEVELS OF PROCOLLAGEN III-N PEPTIDE IN PATIENTS WITH UNTREATED GRAVES’OPHTALMOPATHY WITH OR WITHOUT HYPERTHYROIDISM. 109
New approach study of Graves' Ophtalmopaty: standardized A-Scan echography and Octreotide scintigraphy as possible parameters for disease activi 107
Standardized A-Scan echography and Octreotide scintigraphy are possible parameters for disease activity in Graves' Ophthalmopaty 107
Longitudinal study of vasopressin-cell antibodies and of hypothalamic-pituitary region on magnetic resonance imaging in patients with autoimmune and idiopathic complete central diabetes insipidus 106
Indium-111 octreotide in Graves' disease and in the evaluation of active exophthalmos 106
Growth hormone impaired secretion and antipituitary antibodies in patients with coeliac disease and poor catch-up growth after a long gluten-free diet period: a causal association? 104
Sindromi poliendocrine autoimmuni 103
Pituitary Autoimmunity 103
sELAM-1 e sICAM-1 come possibili markers di predittività per lo sviluppo di IDDM in soggetti con iperglicemia transitoria 103
Cell-mediated immunity in Graves' disease: evaluation by count of rosette-forming cells 100
Amniotic fluid reverse triiodothyronine in normal and high risk pregnancies 98
Totale 14.150
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.475
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.475
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022558 0 0 0 27 230 6 7 16 28 30 52 162
2022/20231.693 153 49 24 185 151 162 0 103 790 15 30 31
2023/2024574 65 29 17 63 183 108 1 19 1 6 29 53
2024/20251.534 9 18 32 67 237 253 197 120 181 184 107 129
2025/20267.118 227 294 390 261 607 4.148 295 375 248 95 104 74
2026/20271.127 47 172 481 427 0 0 0 0 0 0 0 0
Totale 15.052